Compare BridgeBio Pharma Inc (BBIO) vs Eni SpA (E) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Eni SpA — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Eni SpA trades at $49.51 (market cap $71.48B). The key difference: Eni SpA is far larger — about 4.4× BridgeBio Pharma Inc's market cap, and Eni SpA pays a 4.94% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | E | |
|---|---|---|
Market Cap | $16.27B | $71.48B |
Sector | Health | Energy |
52-Week High | $90.17 | $57.61 |
52-Week Low | $44.81 | $32.93 |
Enterprise Value | $17.82B | $90.39B |
Dividend Yield | — | 4.94% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
